Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H21N5O4 |
Molecular Weight | 371.3904 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CNC2=NC=NC3=C2N=CN3[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)C=CC=C1
InChI
InChIKey=OOEMZCZWZXHBKW-SCFUHWHPSA-N
InChI=1S/C18H21N5O4/c1-10-4-2-3-5-11(10)6-19-16-13-17(21-8-20-16)23(9-22-13)18-15(26)14(25)12(7-24)27-18/h2-5,8-9,12,14-15,18,24-26H,6-7H2,1H3,(H,19,20,21)/t12-,14-,15-,18-/m1/s1
Metrifudil (previously known as Y-341) is a synthetic adenosine analog that is acid stable and has a prolonged duration of action. Metrifudil is a selective adenosine A2 receptor agonist and has anticonvulsant activity against seizures. The drug is also studied for the treatment of glomerulonephritis. However, no recent development has been reported.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The hypotensive effect of an oral adenosine analog with selectivity for the A2 receptor in the spontaneously hypertensive rat. | 1995 May |
|
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. | 1999 Jan 1 |
|
Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. | 2008 Oct |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000080946
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
SUB08920MIG
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
23707-33-7
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
2807
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
C082872
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
65710
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
DTXSID1045168
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL331382
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
C87285
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY | |||
|
7K4GKQ4XSE
Created by
admin on Sat Dec 16 17:24:36 GMT 2023 , Edited by admin on Sat Dec 16 17:24:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY